Leprosy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
Condition:   Leprosy Interventions:   Biological: LEP-F1 + GLA-SE;   Biological: Placebo Sponsors:   IDRI;   Oswaldo Cruz Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Areas Endemic for Leprosy
Condition:   Leprosy Interventions:   Biological: LEP-F1 + GLA-SE;   Biological: Placebo Sponsors:   IDRI;   Oswaldo Cruz Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
Condition:   Leprosy Interventions:   Biological: LEP-F1 + GLA-SE;   Biological: Placebo Sponsors:   IDRI;   Oswaldo Cruz Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Areas Endemic for Leprosy
Condition:   Leprosy Interventions:   Biological: LEP-F1 + GLA-SE;   Biological: Placebo Sponsors:   IDRI;   Oswaldo Cruz Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum
Conditions:   Erythema Nodosum Leprosum;   Leprosy Intervention:   Drug: CC-11050 Sponsor:   The Leprosy Mission Nepal Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials